RecruitingPhase 1Phase 2NCT06001593

Modulating Auditory Symptoms and Vertigo of Meniere's Disease by Non-invasive Mastoid Electric Stimulation

Pilot Study of Modulating Auditory Symptoms and Vertigo of Meniere's Disease by Non-invasive Mastoid Electric Stimulation: Double-blind, Randomized, Sham-controlled, Investigator-initiated Trial


Sponsor

Seoul National University Hospital

Enrollment

120 participants

Start Date

Sep 18, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This study is a Double-blind, Randomized, Sham-controlled, Investigator-initiated trial. To explore the effectiveness of non-invasive inner ear electrical stimulation of the mastoid behind the ear in controlling auditory symptoms and dizziness in patients with Meniere's disease.


Eligibility

Min Age: 19 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called YPS-201b, a medical device called YPS-201b, and others for people with meniere's disease. The study is currently recruiting participants at 1 location. People eligible for this study include aged 19 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEYPS-201b

electrical stimulation device.

DRUGbetahistine

Relieve symptoms of balance disorders or dizziness

DEVICEYPS-201b

sham electrical stimulation device.


Locations(1)

Seoul National University Hospital

Seoul, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06001593


Related Trials